Sparing of muscle mass and function by passive loading in an experimental intensive care unit model

Journal of Physiology

Volumn 591, Issue 5, 2013, Pages 1385-1402

  Renaud, Guillaume ^a   Llano Diez, Monica ^a   Ravara, Barbara ^b   Gorza, Luisa ^b   Feng, Han Zhong ^c   Jin, Jian Ping ^c   Cacciani, Nicola ^a   Gustafson, Ann Marie ^a   Ochala, Julien ^a   Corpeno, Rebeca ^a   Li, Meishan ^a   Hedström, Yvette ^a   Ford, G Charles ^d   Nair, K Sreekumaran ^d   Larsson, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF PADOVA   (Italy)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN; PROTEASOME; PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL ADHESION; CELL LEVEL; CELL METABOLISM; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; INTENSIVE CARE UNIT; MECHANICAL STIMULATION; MICROARRAY ANALYSIS; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE DEVELOPMENT; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROCESSING; RAT; TIME; WEIGHT BEARING;

ANIMALS; BIOMECHANICS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; IMMOBILIZATION; INTENSIVE CARE; MUSCLE CONTRACTION; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOSINS; ORGAN SIZE; OXIDATIVE STRESS; PHYSICAL THERAPY MODALITIES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN CARBONYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; TIME FACTORS;

EID: 84874447722     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.248724     Document Type: Article

References (64)

1. 13C]leucine enrichment in human muscle protein. Anal Biochem 239, 77-85.
2. Bando Y, Katayama T, Aleshin AN, Manabe T & Tohyama M (2004). GRP94 reduces cell death in SH-SY5Y cells perturbated calcium homeostasis. Apoptosis 9, 501-508.
3. Barton ER, Park S, James JK, Makarewich CA, Philippou A, Eletto D, Lei H, Brisson B, Ostrovsky O, Li Z & Argon Y (2012). Deletion of muscle GRP94 impairs both muscle and body growth by inhibiting local IGF production. FASEB J 26, 3691-3702.
4. Burns JR & Jones FL (1975). Letter: Early ambulation of patients requiring ventilatory assistance. Chest 68, 608.
5. Burtin C, Clerckx B, Robbeets C, Ferdinande P, Langer D, Troosters T, Hermans G, Decramer M & Gosselink R (2009). Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med 37, 2499-2505.
6. Chen YW, Zhao P, Borup R & Hoffman EP (2000). Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol 151, 1321-1336.
7. Cheung AM, Tansey CM, Tomlinson G, Diaz-Granados N, Matte A, Barr A, Mehta S, Mazer CD, Guest CB, Stewart TE, Al-Saidi F, Cooper AB, Cook D, Slutsky AS & Herridge MS (2006). Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med 174, 538-544.
8. Chong SM & Jin JP (2009). To investigate protein evolution by detecting suppressed epitope structures. J Mol Evol 68, 448-460.
9. Dalla Libera L, Ravara B, Gobbo V, Tarricone E, Vitadello M, Biolo G, Vescovo G & Gorza L (2009). A transient antioxidant stress response accompanies the onset of disuse atrophy in human skeletal muscle. J Appl Physiol 107, 549-557.
10. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphael JC, Outin H & Bastuji-Garin S (2002). Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288, 2859-2867.
11. Dworkin BR & Dworkin S (1990). Learning of physiological responses: I. Habituation, sensitization, and classical conditioning. Behav Neurosci 104, 298-319.
12. Dworkin BR & Dworkin S (2004). Baroreflexes of the rat. III. Open-loop gain and electroencephalographic arousal. Am J Physiol Regul Integr Comp Physiol 286, R597-R605.
13. Essen P, McNurlan MA, Gamrin L, Hunter K, Calder G, Garlick PJ & Wernerman J (1998). Tissue protein synthesis rates in critically ill patients. Crit Care Med 26, 92-100.
14. Fabiato A (1988). Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods Enzymol 157, 378-417.
15. Fanzani A, Musarò A, Stoppani E, Giuliani R, Colombo F, Preti A & Marchesini S (2007). Hypertrophy and atrophy inversely regulate Caveolin-3 expression in myoblasts. Biochem Biophys Res Commun 357, 314-318.
16. 13C)KIC in plasma by capillary gas chromatography/mass spectrometry in protein turnover studies. Biomed Mass Spectrom 12, 432-436.
17. Frontera WR & Larsson L (1997). Contractile studies of single human skeletal muscle fibers: a comparison of different muscles, permeabilization procedures, and storage techniques. Muscle Nerve 20, 948-952.
18. Gamrin L, Essen P, Hultman E, McNurlan MA, Garlick PJ & Wernerman J (2000). Protein-sparing effect in skeletal muscle of growth hormone treatment in critically ill patients. Ann Surg 231, 577-586.
19. Grefte S, Kuijpers-Jagtman AM, Torensma R & Von den Hoff JW (2007). Skeletal muscle development and regeneration. Stem Cells Dev 16, 857-868.
20. Grune T, Merker K, Sandig G & Davies KJ (2003). Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem Biophys Res Commun 305, 709-718.
21. Han B, Zhu MJ, Ma C & Du M (2007). Rat hindlimb unloading down-regulates insulin like growth factor-1 signaling and AMP-activated protein kinase, and leads to severe atrophy of the soleus muscle. Appl Physiol Nutr Metab 32, 1115-1123.
22. Heinemeier KM, Olesen JL, Haddad F, Schjerling P, Baldwin KM & Kjaer M (2009). Effect of unloading followed by reloading on expression of collagen and related growth factors in rat tendon and muscle. J Appl Physiol 106, 178-186.
23. Herridge MS (2011). Recovery and long-term outcome in acute respiratory distress syndrome. Crit Care Clin 27, 685-704.
24. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D & Slutsky AS (2003). One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348, 683-693.
25. Herridge MS, Tansey CM, Matte A, Tomlinson G, Diaz-Granados N, Cooper A, Guest CB, Mazer CD, Mehta S, Stewart TE, Kudlow P, Cook D, Slutsky AS & Cheung AM (2011). Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 364, 1293-1304.
26. Huang da W, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC & Lempicki RA (2007). The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 8, R183.
27. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U & Speed TP (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264.
28. 2+-modulated allosteric domain in the troponin complex. Biochemistry 40, 2623-2631.
29. Kojic S, Medeot E, Guccione E, Krmac H, Zara I, Martinelli V, Valle G & Faulkner G (2004). The Ankrd2 protein, a link between the sarcomere and the nucleus in skeletal muscle. J Mol Biol 339, 313-325.
30. Larsson L (2008). Acute quadriplegic myopathy: an acquired "myosinopathy". Adv Exp Med Biol 642, 92-98.
31. Larsson L & Moss RL (1993). Maximum velocity of shortening in relation to myosin isoform composition in single fibres from human skeletal muscles. J Physiol 472, 595-614.
32. Lee SJ (2010). Extracellular regulation of myostatin: a molecular rheostat for muscle mass. Immunol Endocr Metab Agents Med Chem 10, 183-194.
33. Lee SJ & McPherron AC (2001). Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A 98, 9306-9311.
34. Leijten FS, Harinck-de Weerd JE, Poortvliet DC & de Weerd AW (1995). The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 274, 1221-1225.
35. Lewis SE, Kelly FJ & Goldspink DF (1984). Pre- and post-natal growth and protein turnover in smooth muscle, heart and slow- and fast-twitch skeletal muscles of the rat. Biochem J 217, 517-526.
36. Li C & Wong WH (2001). Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 98, 31-36.
37. Ljungqvist OH, Persson M, Ford GC & Nair KS (1997). Functional heterogeneity of leucine pools in human skeletal muscle. Am J Physiol 273, E564-E570.
38. Llano-Diez M, Gustafson AM, Olsson C, Goransson H & Larsson L (2011). Muscle wasting and the temporal gene expression pattern in a novel rat intensive care unit model. BMC Genomics 12, 602.
39. Llano-Diez M, Renaud G, Andersson M, Gonzales Marrero H, Cacciani N, Engquist H, Corpeno R, Artemenko K, Bergquist J & Larsson L (2012). Mechanisms underlying intensive care unit muscle wasting and effects of passive mechanical loading. Crit Care 16, R209.
40. Martin UJ, Hincapie L, Nimchuk M, Gaughan J & Criner GJ (2005). Impact of whole-body rehabilitation in patients receiving chronic mechanical ventilation. Crit Care Med 33, 2259-2265.
41. 15N isotopic abundances in physiological samples: a pilot study on amino acid synthesis in the upper gastro-intestinal tract of minipigs. J Mass Spectrom 31, 367-376.
42. Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, Ross A, Anderson L, Baker S, Sanchez M, Penley L, Howard A, Dixon L, Leach S, Small R, Hite RD & Haponik E (2008). Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med 36, 2238-2243.
43. Moss RL (1979). Sarcomere length-tension relations of frog skinned muscle fibres during calcium activation at short lengths. J Physiol 292, 177-192.
44. Nava S (1998). Rehabilitation of patients admitted to a respiratory intensive care unit. Arch Phys Med Rehabil 79, 849-854.
45. Nordquist J, Höglund A, Norman H, Tang X, Dworkin B & Larsson L (2007). Transcription factors in muscle atrophy caused by blocked neuromuscular transmission and muscle unloading in rats. Mol Med 13, 461-470.
46. Norman H, Nordquist J, Andersson P, Ansved T, Tang X, Dworkin B & Larsson L (2006). Impact of post-synaptic block of neuromuscular transmission, muscle unloading and mechanical ventilation on skeletal muscle protein and mRNA expression. Pflugers Arch 453, 53-66.
47. North AJ, Galazkiewicz B, Byers TJ, Glenney JR, Jr & Small JV (1993). Complementary distributions of vinculin and dystrophin define two distinct sarcolemma domains in smooth muscle. J Cell Biol 120, 1159-1167.
48. Ochala J, Ahlbeck K, Radell PJ, Eriksson LI & Larsson L (2011a). Factors underlying the early limb muscle weakness in acute quadriplegic myopathy using an experimental ICU porcine model. PLoS One 6, e20876.
49. Ochala J, Gustafson AM, Diez ML, Renaud G, Li M, Aare S, Qaisar R, Banduseela VC, Hedstrom Y, Tang X, Dworkin B, Ford GC, Nair KS, Perera S, Gautel M & Larsson L (2011b). Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: underlying mechanisms. J Physiol 589, 2007-2026.
50. Ochala J, Renaud G, Llano Diez M, Banduseela VC, Aare S, Ahlbeck K, Radell PJ, Eriksson LI & Larsson L (2011c). Diaphragm muscle weakness in an experimental porcine intensive care unit model. PLoS One 6, e20558.
51. Ohsawa Y, Okada T, Kuga A, Hayashi S, Murakami T, Tsuchida K, Noji S & Sunada Y (2008). Caveolin-3 regulates myostatin signaling. Mini-review. Acta Myol 27, 19-24.
52. Ostrovsky O, Ahmed NT & Argon Y (2009). The chaperone activity of GRP94 toward insulin-like growth factor II is necessary for the stress response to serum deprivation. Mol Biol Cell 20, 1855-1864.
53. Ostrovsky O, Eletto D, Makarewich C, Barton ER & Argon Y (2010). Glucose regulated protein 94 is required for muscle differentiation through its control of the autocrine production of insulin-like growth factors. Biochim Biophys Acta 1803, 333-341.
54. Pelosi L, Giacinti C, Nardis C, Borsellino G, Rizzuto E, Nicoletti C, Wannenes F, Battistini L, Rosenthal N, Molinaro M & Musaro A (2007). Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. FASEB J 21, 1393-1402.
55. Pizzo P, Scapin C, Vitadello M, Florean C & Gorza L (2010). Grp94 acts as a mediator of curcumin-induced antioxidant defence in myogenic cells. J Cell Mol Med 14, 970-981.
56. Powers S, Duarte J, Kavazis A & Talbert E (2010). Reactive oxygen species are signalling molecules for skeletal muscle adaptation. Exp Physiol 95, 1-9.
57. Raskin AM, Hoshijima M, Swanson E, McCulloch AD & Omens JH (2009). Hypertrophic gene expression induced by chronic stretch of excised mouse heart muscle. Mol Cell Biomech 6, 145-159.
58. Ross G (1972). A method for augmenting ventilation during ambulation. Phys Ther 52, 519-520.
59. Smyth GK (2004). Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3, Article 3.
60. Suliman IA, Lindgren JU, Gillberg PG, Elhassan AM, Monneron C & Adem A (1999). Alteration of spinal cord IGF-I receptors and skeletal muscle IGF-I after hind-limb immobilization in the rat. Neuroreport 10, 1195-1199.
61. Suzuki N, Motohashi N, Uezumi A, Fukada S, Yoshimura T, Itoyama Y, Aoki M, Miyagoe-Suzuki Y & Takeda S (2007). NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J Clin Invest 117, 2468-2476.
62. Tjader I, Rooyackers O, Forsberg AM, Vesali RF, Garlick PJ & Wernerman J (2004). Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients. Intensive Care Med 30, 266-275.
63. Vitadello M, Penzo D, Petronilli V, Michieli G, Gomirato S, Menabo R, Di Lisa F & Gorza L (2003). Overexpression of the stress protein Grp94 reduces cardiomyocyte necrosis due to calcium overload and simulated ischemia. FASEB J 17, 923-925.
64. Yang CQ, Zhan X, Hu X, Kondepudi A & Perdue JF (1996). The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the O-glycosylation of its E domain. Endocrinology 137, 2766-2773.